Am J Health-Syst Pharm
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barbosa, L. A.
Right arrow Articles by Teixeira, C. R. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barbosa, L. A.
Right arrow Articles by Teixeira, C. R. V.
American Journal of Health-System Pharmacy, Vol. 65, Issue 11, 1048-1050
Copyright © 2008. American Society of Health-System Pharmacists, Inc. All rights reserved. 1079-2082/04/0602-1242$06.00


Case Reports

Erythema multiforme associated with prophylactic use of phenytoin during cranial radiation therapy

Leandro A. Barbosa and Carlos Roberto V. Teixeira

LEANDRO A. BARBOSA, PH.D., M.SC., is Pharmacist, Pharmacy Service, Hospitals of Cancer III and IV; and CARLOS ROBERTO V. TEIXEIRA, M.D., is Oncologist, Oncology Clinic, Hospital of Cancer III, National Cancer Institute, Rio de Janeiro, Brazil.

Address correspondence to Dr. Barbosa at the Instituto Nacional de Câncer, Setor de Farmácia HCIII/HCIV, Rua Visconde de Santa Isabel 274, 20560-120 Rio de Janeiro, Brazil (leaugust{at}yahoo.com.br).


Purpose. A case of erythema multiforme associated with prophylactic use of phenytoin during cranial radiation therapy is reported.

Summary. A 60-year-old woman with intraductal adenocarcinoma of the breast and cerebral metastasis who had an implanted central venous catheter arrived at the hospital for the treatment of cerebral metastasis. She underwent whole brain irradiation and was given a total dose of 3750 cGy over 15 fractional doses spaced over three weeks. At the beginning of cranial radiation therapy, prophylactic oral ranitidine, oral dexamethasone, and oral phenytoin were initiated to prevent seizures. After 30 days of continuous prophylactic phenytoin and cranial radiation therapy, the patient developed an episode of coughing with yellow sputum, mucositis, and a minor skin reaction that was diagnosed in the emergency department as radiotherapy-associated lesions. After 2 days, the patient returned to the hospital with severe mucositis and an erythematous macular eruption on the scalp and auricular region within the radiation field. These were believed to be due to the radiation therapy, and the patient was subsequently hospitalized. The eruption dramatically extended over the next day, with itching micropapular urticarial lesions over large areas of the face, trunk, and genital region. The condition had worsened by the next day, with erythematous eruptions on the whole body (including the extremities), skin detachment, and vesicular lesions on the eyelids. The patient was then diagnosed toxic epidermal necrolysis.

Conclusion. A patient with intraductal adenocarcinoma of the breast and cerebral metastasis developed erythema multiforme after receiving concurrent phenytoin and radiation therapy.

Index terms: Anticonvulsants; Dexamethasone; Erythema multiforme; Neoplasm metastasis; Phenytoin; Radiation; Ranitidine; Seizures; Toxicity

 






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Society of Health-System Pharmacists.